Layden TJ - Search Results

1

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.

Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T, Cheung RC. Huang H, et al. Among authors: layden tj. Hepatology. 2007 Aug;46(2):297-306. doi: 10.1002/hep.21695. Hepatology. 2007. PMID: 17461418 Free article.

2

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, Broder S, White T, Sninsky JJ, Wright TL. Huang H, et al. Among authors: layden tj. Gastroenterology. 2006 May;130(6):1679-87. doi: 10.1053/j.gastro.2006.02.032. Epub 2006 Mar 6. Gastroenterology. 2006. PMID: 16697732

3

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Wiley TE, et al. Among authors: layden tj. Hepatology. 1998 Sep;28(3):805-9. doi: 10.1002/hep.510280330. Hepatology. 1998. PMID: 9731576

4

Dynamics of alanine aminotransferase during hepatitis C virus treatment.

Ribeiro RM, Layden-Almer J, Powers KA, Layden TJ, Perelson AS. Ribeiro RM, et al. Among authors: layden almer j, layden tj. Hepatology. 2003 Aug;38(2):509-17. doi: 10.1053/jhep.2003.50344. Hepatology. 2003. PMID: 12883496

5

The 20th United States-Japan Joint Hepatitis Panel Meeting.

Lemon SM, Layden TJ, Seeff L, Suzuki H, Nishioka K, Mishiro S, Johnson L. Lemon SM, et al. Among authors: layden tj. Hepatology. 2000 Mar;31(3):800-6. doi: 10.1002/hep.510310338. Hepatology. 2000. PMID: 10706578 No abstract available.

6

Hepatitis B virus clearance rate estimates.

Dahari H, Cotler SJ, Layden TJ, Perelson AS. Dahari H, et al. Among authors: layden tj. Hepatology. 2009 May;49(5):1779-80; author reply 1780-1. doi: 10.1002/hep.22874. Hepatology. 2009. PMID: 19402118 No abstract available.

7

Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling.

Dahari H, Cotler SJ, Layden TJ, Perelson AS. Dahari H, et al. Among authors: layden tj. J Hepatol. 2013 Apr;58(4):840-2. doi: 10.1016/j.jhep.2012.08.029. Epub 2012 Dec 13. J Hepatol. 2013. PMID: 23246507 Free PMC article. No abstract available.

8

Constipation: is it a risk factor for cholesterol gallstones?

Watkins JL, Wiley TE, Layden TJ. Watkins JL, et al. Among authors: layden tj. Hepatology. 1993 Aug;18(2):457-8. Hepatology. 1993. PMID: 8340076 Free article. No abstract available.

9

Risk factors for failure to meet listing requirements in liver transplant candidates with alcoholic cirrhosis.

Karman JF, Sileri P, Kamuda D, Cicalese L, Rastellini C, Wiley TE, Layden TJ, Benedetti E. Karman JF, et al. Among authors: layden tj. Transplantation. 2001 May 15;71(9):1210-3. doi: 10.1097/00007890-200105150-00005. Transplantation. 2001. PMID: 11397951

10

Ethnic differences in the presentation of chronic hepatitis C.

Lepe R, Layden-Almer JE, Layden TJ, Cotler S. Lepe R, et al. Among authors: layden tj, layden almer je. J Viral Hepat. 2006 Feb;13(2):116-20. doi: 10.1111/j.1365-2893.2005.00672.x. J Viral Hepat. 2006. PMID: 16436129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page